谷歌浏览器插件
订阅小程序
在清言上使用

Phase Ib/II Study on the Safety, Tolerability, and Preliminary Efficacy of Pegylated Irinotecan (JK1201I) As Second‐line Monotherapy for Patients with Small‐cell Lung Cancer

Cancer Medicine(2024)

引用 0|浏览0
暂无评分
关键词
overall survival,safety,second-line monotherapy,small-cell lung cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要